Notice of Change to Foreign Component Eligibility in PAR-23-282 "NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)"
Notice Number:
NOT-AI-24-088

Key Dates

Release Date:

October 8, 2024

Related Announcements

  • November 03, 2023 - NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed).  See NOFO PAR-23-282.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform applicants of a correction to the eligibility of foreign components in PAR-23-282, "NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)". The Notice of Funding Opportunity (NOFO) has been revised to indicate that foreign components are allowed. Therefore, Part 2. Section III. Eligibility Information is updated as follows.


Currently Reads:

Part 2. Full Text of Announcement

Section III. Eligibility Information

1. Eligible Applicants

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. 


Modified to Read (changes shown in bold italics):

Part 2. Full Text of Announcement

Section III. Eligibility Information

1. Eligible Applicants

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 


All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Office of Research Training and Special Programs (ORTSP)
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-594-5945
Email: [email protected]